Table 1.
Baseline characteristics of patients
| Number (%) | |
|---|---|
| Mean age (year) |
65.6 ± 14.0 |
| Male gender |
88 (57.5%) |
|
Medical history | |
| Hypertension |
127 (85%) |
| Diabetes |
69 (46%) |
| Oral hypoglycaemics |
25 (17%) |
| Insulin |
34 (23%) |
| Heart failure |
20 (13%) |
| Stroke |
23 (15%) |
| Hyperlipidaemia |
90 (60%) |
| Current smoker |
15 (10%) |
| Atrial fibrillation |
10 (6.5%) |
| AMI |
30 (20%) |
| PCI |
25 (16%) |
| CABG |
17 (11%) |
| Patients on dialysis |
56 (37%) |
| Haemodialysis |
45 (29%) |
| Peritoneal dialysis |
13 (8%) |
|
Aetiology of kidney disease: | |
| Diabetes |
48 (31%) |
| Glomerulonephritis |
39 (25%) |
| Vascular |
13 (8%) |
| Hypertension |
10 (7%) |
| Vesicoureteric reflux |
9 (6%) |
| Congenital |
6 (4%) |
| Other |
28 (18%) |
|
Medications | |
| ACEI/ARB |
86 (56%) |
| Diuretic |
58 (38%) |
| Beta blocker |
64 (42%) |
| Statin |
92 (60%) |
| Calcium antagonist |
60 (39%) |
| Aspirin |
42 (27%) |
| EPO | 65 (42%) |